Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02624024 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of AQT90 FLEX TnI and TnT
A clinical trial, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- 1,743
- Enrollment target
NCT02624024 is a clinical trial that has completed, run by Radiometer Medical ApS. The registered enrollment target is 1,743 participants.
The verdict
NCT02624024 has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- 1,743 participants
- Enrollment target
Study Summary
The AQT90 FLEX Troponin I (TnI) and Troponin T (TnT) Tests are in vitro diagnostic assays intended as an aid in the diagnosis of myocardial infarction (MI) in point-of-care and laboratory settings. The purpose of the study is to establish the clinical performance of the AQT90 FLEX TnI and TnT assays for both whole blood and plasma in the intended use population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,743 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02624024
The ClinicalTrials.gov registry entry for NCT02624024 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,743 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiometer Medical ApS, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02624024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02624024 about?
NCT02624024 is a clinical study titled "Clinical Performance Evaluation of AQT90 FLEX TnI and TnT". The AQT90 FLEX Troponin I (TnI) and Troponin T (TnT) Tests are in vitro diagnostic assays intended as an aid in the diagnosis of myocardial infarction (MI) in point-of-care and laboratory settings. The purpose of the study is to establish the clinical performance of the AQT90 FLEX TnI and TnT assays...
What is the current status of trial NCT02624024?
This trial is currently completed. The enrollment target is 1,743 participants. The study started on 2016-01. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT02624024?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.